Given the crucial role of MST1 in the pancreatic β cells and in the pathogenesis of DM, we hypothesized that treatment with XMU-MP-1 would produce beneficial effects by improving the survival and function of the pancreatic β cells. This evidence concerns the gene MST1 and diabetes mellitus.